The
bio-tech market is full of activity with significant shifts surrounding
AT&T Inc. (T). The communications giant's shares have experienced movements in both directions. Steady trading was seen as we entered the New Year with traders eyeing January 28th earnings. Substantial stock positions were held by
CapWealth Advisors and obtained by
Silver Oak Securities and the
Virginia Retirement Systems. Meanwhile,
Calamos Advisors and
Fort Washington Investment Advisors have sold shares. AT&T is competing in the
digital switching space with T-Mobile, and Verizon is intensifying holiday promotions. Despite a 12.4% rally, due to new satellite partnerships, the valuation of AT&T's stock has been trimmed to $29. In other news,
AT&T announces a dual listing on NYSE Texas and maintains its commitment to higher share buybacks through 2029. Important factors contribute to the volatility of its stock including the plans for $20 billion in stock buybacks through 2027. Still, AT&T's
dividend remains sustainable, showing both yield and reinvention.
Goldman Sachs forecasts free cash flow growth helping to fuel further buybacks.
Att Stocks News Analytics from Mon, 19 May 2025 07:00:00 GMT to Sat, 03 Jan 2026 11:47:16 GMT -
Rating 6
- Innovation 2
- Information 8
- Rumor 4
